What Ibuprofen Wockhardt Treats: Main Uses and Benefits

Ibuprofen Wockhardt is commonly used to provide symptomatic relief across three universal symptom axes: pain, inflammation, and fever. The medication is generally applied in contexts where short-term symptomatic assistance is needed, often in situations where symptoms create noticeable physiological strain or interfere with daily functioning.

Therapeutic Domains

The therapeutic domain helps address symptom clusters related to inflammatory or irritative states, with symptoms associated with conditions such as headaches, dental pain, fever, menstrual cramps (primary dysmenorrhea), Osteoarthritis, and Rheumatoid Arthritis. The benefit generally assists with maintaining functional stability and contributes to improved day-to-day comfort during symptomatic periods.

“This medication is relevant across domains where additional symptomatic support is needed to cope with periods of heightened discomfort or systemic burden.”

It is applied in clinical settings that involve acute or unstable symptom patterns, such as post-traumatic sprains and strains, and helps manage discomfort and malaise often linked to the common cold or flu. This contributes to easing the overall symptom load and helps patients cope more steadily with temporary symptomatic phases.

Quick Fact: Relief for Inflammation and Discomfort
Ibuprofen is commonly used for easing symptoms related to both acute tissue irritation (e.g., dental pain, minor injury) and the chronic inflammation of arthritic conditions.

Regulatory References

1. NIH MedlinePlus overview of Ibuprofen uses

Official Eligibility and Contraindications

The eligibility for Ibuprofen Wockhardt, a nonsteroidal anti-inflammatory drug (NSAID), is strictly governed by authoritative regulatory documentation defining absolute contraindications and mandatory restrictions.

Classification	Who Must NOT Use (Contraindications)
Allergy History	Patients with known hypersensitivity to Ibuprofen, aspirin, or other NSAIDs (e.g., those who experienced asthma, urticaria, or allergic reactions).
Organ Dysfunction	Patients with severe heart failure (NYHA Class IV), severe renal failure, or severe hepatic failure (or severe liver disease).
Bleeding Risk	Patients with active or recurrent peptic ulcer/haemorrhage or those in the setting of coronary artery bypass graft (CABG) surgery.

Age and Pregnancy Rules

• Children Under 12: Use is generally not established or not recommended for certain formulations unless specifically advised by a physician.
• Pregnancy (Third Trimester): Use is prohibited/contraindicated from 30 weeks gestation onward due to risk of fetal cardiovascular and renal issues. Use from 20 to 30 weeks should be limited to the lowest effective dose for the shortest duration possible, as advised by a professional.

Restricted/Conditional Use

Patients with mild-to-moderate heart failure, hypertension, mild renal or hepatic impairment, and the elderly are eligible but must use the medicine with special caution and adhere to the lowest effective dose for the shortest treatment duration to mitigate cardiovascular and gastrointestinal risks.

Interactions with other medicines and products

Ibuprofen may interact with several medicinal products, influencing the activity of the concurrent medication or increasing the risk of adverse effects. Concomitant use with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), including COX-2 specific inhibitors, is generally not recommended due to an elevated risk of gastrointestinal bleeding or ulceration.

Clinically significant interactions occur with Anticoagulants (such as warfarin) and Antiplatelet agents (including low-dose aspirin), which significantly increase the risk of serious bleeding. Ibuprofen may interfere with the intended antiplatelet effect of low-dose aspirin, though this interference may be reduced if immediate-release aspirin is taken at least two hours prior to a once-daily dose of ibuprofen. This timing condition does not apply to enteric-coated aspirin.

The drug may also diminish the blood pressure-lowering effect of Angiotensin-Converting Enzyme (ACE) inhibitors and reduce the effectiveness of Diuretics (e.g., furosemide). Caution and close patient monitoring are required when co-administering Ibuprofen with Lithium or Methotrexate, as Ibuprofen can increase the plasma concentrations and potential toxicity of these medicines. Concomitant use with Selective Serotonin Re-uptake Inhibitors (SSRIs) and Oral Corticosteroids is associated with an increased risk of gastrointestinal complications.

Modulation of Eicosanoid Signaling in the COX Pathway

Ibuprofen Wockhardt is a reversible, non-selective inhibitor of the Cyclooxygenase ( COX) enzymes. The drug's physiological effects are derived from this core mechanism, which modulates COX pathway signaling in both peripheral tissues and the central nervous system ( CNS). Its primary action is the competitive inhibition of COX-1 and COX-2 enzymes, which halts the initial molecular step in the Arachidonic Acid Cascade. By suppressing the synthesis of key mediators like Prostaglandin E2 ( PGE2) at the site of heightened activity, the drug limits the production of chemical signals that promote vascular changes and nerve sensitization.

---

Dual Action on Central Thermoregulation and Nociception

This molecular blockade results in two distinct physiological consequences. Centrally, the suppression of PGE2 synthesis in the hypothalamus leads to a resetting of the core body temperature setpoint, which initiates cooling mechanisms like vasodilation. Peripherally, the reduced PGE2 concentration limits the ability of other chemical mediators to sensitize peripheral nerve endings, thereby raising the threshold required for pain signal transmission.

Official Administration and Dosing Guidelines

Ibuprofen Wockhardt is intended exclusively for oral administration as a tablet, caplet, or liquid suspension. Adherence to provided dosing and administration instructions is important, and maximum doses must not be exceeded.

---

Standard Dosing and Frequency

Regimen	Single Dose Range	Maximum Total Daily Dose
Non-Prescription (OTC) Use	200 mg to 400 mg	1200 mg
Prescription (Rx) Use	400 mg to 800 mg	Up to 3200 mg (in divided doses)

For adults and adolescents, the standard interval between doses is 4 to 6 hours as needed, with a required minimum of four hours between administrations. Treatment for acute symptoms using non-prescription doses is generally restricted to short-term use, typically no longer than 10 days, unless directed otherwise by a healthcare professional.

---

Administration Conditions and Adjustments

Context of Use: Tablets and caplets should be swallowed whole with a full glass of water. To reduce the potential for stomach discomfort, it is advised to take the medicine with or immediately after food or milk.

Pediatric Dosing: Dosing for children younger than 12 years is weight-based, commonly calculated as 5 mg/kg to 10 mg/kg per dose for fever and pain. For liquid formulations, the suspension must be shaken well before measuring the dose, and a calibrated dosing device should be used.

Special Populations: Guidelines generally recommend caution and close monitoring for older adults and patients with mild to moderate renal or hepatic impairment, often requiring the use of the lowest effective dose. Use is strictly contraindicated in cases of severe organ failure.

Research Evidence / Overview of Studies for Ibuprofen Wockhardt

The research base for pain relief was studied for short-term relief and is derived from short-term Randomized Controlled Trials (RCTs) and subsequent meta-analyses. These investigations were applied in studies examining patient-reported experiences of acute pain, such as headaches, dental pain, and musculoskeletal discomfort. Researchers primarily monitored outcomes related to physical discomfort by measuring changes in pain intensity using validated scales. Research has examined study results that reflect specific conditions, with findings indicating patterns observed in studies where pain intensity was measured at defined time intervals, typically ranging from 60 minutes up to 24 hours.

---

Evidence for Use in Fever Reduction (Antipyretic Action)

Fever reduction was evaluated in numerous short-term RCTs and systematic reviews comparing the medication to other antipyretic agents. These studies were conducted during periods of temporary physiological imbalance. Primary outcomes monitored physiological strain by measuring the continuous change in body temperature and determining the likelihood of a subject achieving an afebrile state. The research highlights changes measured in body temperature, with the most noticeable patterns typically observed within the first few hours after administration. Data show patterns related to temperature changes that were also observed when other fever-reducing medications were studied in some trials.

---

Evidence for Use in Chronic Inflammatory Conditions

The evidence base for chronic inflammatory conditions, such as Osteoarthritis (OA) and Rheumatoid Arthritis (RA), was evaluated in Controlled Clinical Trials and Prospective Observational Studies. Research examined outcomes reflecting daily functioning and activity level in conditions marked by functional limitations. Studies monitored responses over defined time intervals, with follow-up durations ranging from several months up to one year.

---

What is Still Uncertain About Ibuprofen Wockhardt Research

One key limitation is the concept of the analgesic ceiling, where research examined whether additional dosage was associated with an incremental measured change in pain relief outcomes. Limited comparative evidence is available regarding how the drug performs against newer non-steroidal anti-inflammatory drugs across all specific indications. Furthermore, data are still emerging, and research is ongoing, to fully establish the potential long-term effects of chronic, high-dose use on certain physiological systems.

Common questions about Ibuprofen Wockhardt (FAQ)

---

Q: What is the proper way to store this medicine?

Official product information states that this medicine should be stored at a controlled room temperature. This is typically defined as between 20 C to 25 C (68 F to 77 F). To maintain its stability, the product labeling advises avoiding exposure to excessive heat.

---

Q: Is it safe to take this product with alcohol?

Regulatory warnings advise patients to avoid drinking alcohol while taking this medicine. Alcohol may significantly increase the risk of stomach bleeding, which is a known side effect associated with the ibuprofen component of the product. For this reason, combining the two is advised against in the official product labeling.

---

Q: Can I use this product if I have high blood pressure?

The official product monograph advises using this medicine with caution if you have hypertension (high blood pressure). The pseudoephedrine component is a sympathomimetic amine, which means it can affect the circulatory system. Patients with pre-existing high blood pressure are advised to consult with a healthcare professional before use.

---

Q: Is this product safe for pregnant or breastfeeding women?

Official regulatory documents indicate that this product is generally contraindicated (should not be used) during the third trimester of pregnancy. For use during other trimesters or while breastfeeding, speaking with a healthcare professional is generally recommended. The components of the product are associated with potential risks to the developing fetus or nursing infant.

---

Q: Does this medication cause drowsiness or make you sleepy?

While not primarily labeled as causing drowsiness, the official documentation notes that this product may cause side effects like dizziness or shakiness. The decongestant component may also be stimulating for some people. Due to these potential effects, the product monograph suggests that use close to bedtime should be avoided.

---

Q: How long can I take this medication?

The product monograph specifies limits on the duration of use. The product monograph advises against taking this medicine for a fever for more than 3 days. For cold symptoms or pain, the official recommendation is to not exceed 5 days. If using it for a sore throat, limits are typically set to no more than 2 days.

Storage and Disposal Requirements

Official regulatory documents define specific requirements for storing and disposing of this medicine to maintain its stability and ensure environmental protection.

Storage Conditions

Requirement	Official Instruction
Temperature	Do not store above 25degree C.
Protection	Store in the original container and outer carton to protect from light and moisture.
Children	Keep out of the sight and reach of children.

Disposal Protocol

Medicines that are no longer needed or have expired must be disposed of according to strict environmental protocols. Do not throw away any medicines via wastewater or household waste. Unused or expired medication should be returned to the pharmacist for proper disposal. This required action helps to protect the environment by ensuring appropriate handling as pharmaceutical waste.